Voluntary recall of Multiple Batches of Product: Lorivan 2mg Tab
2026-09-03
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Lorivan 2mg Tab Lorazepam غير مسجل 104173 , 96754, 125313 REMEDICA LTD – Cyprus
التصنيف
Health practitioners
التاريخ
2026-09-03
اسم المستحضر
Lorivan 2mg
نوع المستحضر
Medicine Product
اجراء الاستدعاء
Wholesale level
مستوى الاستدعاء
Hospital level
سبب السحب
The Saudi Food and Drug Authority (SFDA) has issued Voluntary recall Multiple Batches of Product Lorivan 2mg due to Out-of-specification (OOS) results identified during the ongoing stability study, which may affect the quality and safety of the product .
التوصيات
For healthcare professionals: Stop dispensing the batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.